JOHNSON & JOHNSON (JNJ:NYSE)
$238.46 -2.85 (-1.1811%)
Analysed JOHNSON & JOHNSON (JNJ:NYSE) News Sources
Which Dividend Pharma Stock Should a Value Investor Choose Today?
13-04-2026
fool.com
Goldman Sachs, Bank of America, JP Morgan, Netflix, J&J, Producer Prices, and More to Watch This Week
12-04-2026
yahoo.com
Better Buy Right Now: Johnson & Johnson Vs. Pfizer
12-04-2026
fool.com
Johnson & Johnson (JNJ) Valuation Check As TECNIS PureSee IOL Data Take Center Stage
11-04-2026
yahoo.com
The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026
11-04-2026
fool.com
This Startup’s Psoriasis Drug Studies Have Lifted Its Stock
10-04-2026
yahoo.com
Earnings Season Ramps Up: What to Watch in the Next Week
10-04-2026
yahoo.com
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
10-04-2026
yahoo.com
How The Narrative On Johnson & Johnson (JNJ) Is Shifting With New Targets And Litigation Risks
10-04-2026
yahoo.com
Could Buying This Dividend Pharma Stock Today Set You Up for Life?
10-04-2026
fool.com
What is the current price of JOHNSON & JOHNSON (JNJ:NYSE)?
The current price of JOHNSON & JOHNSON (JNJ:NYSE) is $238.46.
JOHNSON & JOHNSON (JNJ:NYSE) absolute price change since previous trading day?
The absolute price change of JOHNSON & JOHNSON (JNJ:NYSE) since the previous trading day is $-2.85.
JOHNSON & JOHNSON (JNJ:NYSE) percentage price change since previous trading day?
The percentage price change of JOHNSON & JOHNSON (JNJ:NYSE) since the previous trading day is -1.1811%.
What is the most recent average sentiment score for JOHNSON & JOHNSON (JNJ:NYSE)?
The most recent average sentiment score for JOHNSON & JOHNSON (JNJ:NYSE) is 76 out of 100.
What is the most recent average sentiment for JOHNSON & JOHNSON (JNJ:NYSE)?
The most recent sentiment for JOHNSON & JOHNSON (JNJ:NYSE) is .
SEC-8K** Filing Available For JOHNSON & JOHNSON (JNJ:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.